Literature DB >> 31168642

Cannabidiol: a hope to treat non-motor symptoms of Parkinson's disease patients.

Sidra Saleem1, Arsalan Anwar2.   

Abstract

Entities:  

Year:  2019        PMID： 31168642     DOI： 10.1007/s00406-019-01023-y

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN： 0940-1334            Impact factor:   5.270


× No keyword cloud information.
  4 in total

1.  Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial.

Authors:  Marcos Hortes N Chagas; Antonio W Zuardi; Vitor Tumas; Márcio Alexandre Pena-Pereira; Emmanuelle T Sobreira; Mateus M Bergamaschi; Antonio Carlos dos Santos; Antonio Lucio Teixeira; Jaime E C Hallak; José Alexandre S Crippa
Journal:  J Psychopharmacol       Date:  2014-09-18       Impact factor: 4.153

Review 2.  Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?

Authors:  José Alexandre S Crippa; Jaime E C Hallak; Antônio W Zuardi; Francisco S Guimarães; Vitor Tumas; Rafael G Dos Santos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-31       Impact factor: 5.270

Review 3.  Risk factors for non-motor symptoms in Parkinson's disease.

Authors:  Johan Marinus; Kangdi Zhu; Connie Marras; Dag Aarsland; Jacobus J van Hilten
Journal:  Lancet Neurol       Date:  2018-04-23       Impact factor: 44.182

Review 4.  Cannabidiol as a Promising Strategy to Treat and Prevent Movement Disorders?

Authors:  Fernanda F Peres; Alvaro C Lima; Jaime E C Hallak; José A Crippa; Regina H Silva; Vanessa C Abílio
Journal:  Front Pharmacol       Date:  2018-05-11       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.